Skip to main content
Top
Published in: Abdominal Radiology 11/2023

14-09-2023 | Metastasis | Hepatobiliary

Deep learning-based iodine contrast-augmenting algorithm for low-contrast-dose liver CT to assess hypovascular hepatic metastasis

Authors: Taehee Lee, Jeong Hee Yoon, Jin Young Park, Jihyuk Lee, Jae Won Choi, Chulkyun Ahn, Jeong Min Lee

Published in: Abdominal Radiology | Issue 11/2023

Login to get access

Abstract

Purpose

To investigate the image quality and diagnostic performance of low-contrast-dose liver CT using a deep learning-based iodine contrast-augmenting algorithm (DLICA) for hypovascular hepatic metastases.

Methods

This retrospective study included 128 patients who underwent contrast-enhanced dual-energy CT for hepatic metastasis surveillance between July 2019 and June 2022 using a 30% reduced iodine contrast dose in the portal phase. Three image types were reconstructed: 50-keV virtual monoenergetic images (50-keV VMI); linearly blended images simulating 120-kVp images (120-kVp); and post-processed 120-kVp images using DLICA (DLICA 120-kVp). Three reviewers evaluated lesion conspicuity, image contrast, and subjective image noise. We also measured image noise, contrast-to-noise ratios (CNRs), and signal-to-noise ratios (SNRs). The diagnostic performance for hepatic metastases was evaluated using a jackknife alternative free-response receiver operating characteristic method with the consensus of two independent radiologists as the reference standard.

Results

DLICA 120-kVp demonstrated significantly higher CNR of lesions to liver (5.7 ± 3.1 vs. 3.8 ± 2.1 vs. 3.8 ± 2.1) and higher SNR compared with 50-keV VMI and 120-kVp (< 0.001 for all). DLICA 120-kVp had significantly lower image noise than 50-kVp VMI for all regions (< 0.001 for all). DLICA 120-kVp also exhibited superior lesion conspicuity (4.0 [3.3–4.3] vs. 3.7 [3.0–4.0] vs. 3.7 [3.0–4.0]), higher image contrast, and lower subjective image noise compared with 50-keV VMI and 120-kVp (< 0.001 for all). Although there was no significant difference in the figure of merit for lesion diagnosis among the three methods (= 0.11), DLICA 120-kVp had a significantly higher figure of merit for lesions with a diameter < 20 mm than 50-keV VMI (0.677 vs. 0.648, = 0.007). On a per-lesion basis, DLICA 120-kVp also demonstrated higher sensitivity than the 50-keV VMI (81.2% vs. 72.9%, < 0.001). The specificities per lesion were not significantly different among the three algorithms (= 0.15).

Conclusion

DLICA at 120-kVp provided superior lesion conspicuity and image quality and similar diagnostic performance for hypovascular hepatic metastases compared with 50-keV VMI.

Graphical abstract

Appendix
Available only for authorised users
Literature
12.
15.
Metadata
Title
Deep learning-based iodine contrast-augmenting algorithm for low-contrast-dose liver CT to assess hypovascular hepatic metastasis
Authors
Taehee Lee
Jeong Hee Yoon
Jin Young Park
Jihyuk Lee
Jae Won Choi
Chulkyun Ahn
Jeong Min Lee
Publication date
14-09-2023
Publisher
Springer US
Published in
Abdominal Radiology / Issue 11/2023
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-023-04039-0

Other articles of this Issue 11/2023

Abdominal Radiology 11/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.